Martinus M. van Veen

Martinus M. van Veen

Auto-generated profile, based on publicly available information

Martinus M. van Veen

Department of Plastic Surgery, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2018 in The Laryngoscope
Verified
Journal Article
Open access
PDF file
MVMartinus M. van Veen
Martinus M. van Veen
JDJoseph R. Dusseldorp
Joseph R. Dusseldorp
THTessa A. Hadlock
Tessa A. Hadlock
Objective: The objective of this study was to investigate the long‐term effect and treatment stability of selective neurectomy for refractory periocular synkinesis.Methods: We performed a retrospective review of all patients treated with highly selective neurectomy for refractory periocular synkinesis between August 2009 and August 2015. Primary outcome was time to recommencing treatment for periocular synkinesis. Palpebral fissure width was measured preoperatively, postoperatively, and at long‐term ( > 2.5 years) follow‐up. Mean units of botulinum toxin used pre‐ and postoperatively were compared.Results: Of the 12 patients, 10 could be included. Only one was free of treatment for periocular synkinesis at a follow‐up of 3.5 years. The other nine patients recommenced treatment with botulinum toxin after a median time of 1.2 (interquartile range 0.6–2.6) years. Palpebral fissure width while smiling was significantly different between the pre‐ and postoperative (P = 0.008) and preoperative and long‐term (P = 0.008) measurements. Postoperatively, previously refractory patients demonstrated good response to botulinum toxin treatments.Conclusion: This study demonstrates that most patients require renewed pharmacological treatment of periocular synkinesis after neurectomy. Although the effect of neurectomy in the treatment of refractory synkinesis does not appear to be sustained, patients usually experience a symptom‐free interval and demonstrate larger palpebral fissure width at long‐term follow‐up compared to preoperative measurements.Level of Evidence: 4. Laryngoscope, 128:2291–2295, 2018

3 March 2019 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
MVMartinus M. van Veen
Martinus M. van Veen
OQOlivia Quatela
Olivia Quatela
JTJoana Tavares‐Brito
Joana Tavares‐Brito
MRMara Robinson
Mara Robinson
JBJennifer H. Baiungo
Jennifer H. Baiungo
THTessa A. Hadlock
Tessa A. Hadlock

17 January 2019 in JAMA Facial Plastic Surgery
Verified
Journal Article
Open access
PDF file
MVMartinus M. van Veen
Martinus M. van Veen
JTJoana Tavares-Brito
Joana Tavares-Brito
BVBritt M. van Veen
Britt M. van Veen
JDJoseph R. Dusseldorp
Joseph R. Dusseldorp
PWPaul M. N. Werker
Paul M. N. Werker
THTessa A. Hadlock
Tessa A. Hadlock
Importance: Study of the association of regional facial dysfunction with quality of life will lead to a better understanding of quality of life in facial palsy. Objective: To determine the association of regional facial dysfunction with facial palsy–related quality of life. Design, Setting, and Participants: This retrospective cohort analysis included patients with flaccid and nonflaccid (synkinetic) facial palsy treated at a tertiary care facial nerve center; the flaccid facial palsy group included 529 patients, and the nonflaccid facial palsy group included 391 patients. Data were included from all patients with facial palsy who had an eFACE score and Facial Clinimetric Evaluation (FaCE) scale total score acquired at the same time from February 1, 2014, through October 31, 2017. Linear regression analysis was performed to calculate the amount of variance in quality of life explained by the severity of facial palsy (eFACE). A relative weight analysis was performed for the contribution of each individual eFACE item in estimating quality of life. Main Outcomes and Measures: Facial palsy severity was measured using all 15 individual eFACE items (rated on a scale of 0 to 200, where 0 represents complete flaccidity, 100 represents a balanced aesthetic appearance, and 200 represents the worst imaginable hypertonia of a patient with synkinesis, with a transformation used for values from 101 to 200), and facial palsy–related quality of life was measured using the FaCE scale total score (range, 0 [worst] to 100 [best]). Results: Data of 920 individual patients (59.5% female; mean [SD] age, 48.6 [16.6] years) were available. The eFACE composite score accounted for 21.2% of the quality-of-life variance in the flaccid group and 13.9% in the nonflaccid group. With the use of all 15 individual eFACE items, these proportions increased to 29.7% and 16.8%, respectively. In both groups, oral commissure movement with smile was found to be the most important contributing item (relative weight, 0.108 [95% CI, 0.075-0.148] for the flaccid group and 0.025 [95% CI, 0.005-0.052] for the nonflaccid group). Items related to the function of periocular muscles were found to be of low importance. Conclusions and Relevance: The present study suggests that the function of individual facial regions is not equally important for estimating facial palsy–related quality of life. The ability to smile is of greatest importance among patients with flaccid and nonflaccid facial palsy. The true importance of periocular function in the estimation of quality of life should be studied further in future research. Level of Evidence: NA .

1 November 2017 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
MVMartinus M. van Veen
Martinus M. van Veen
PDPieter U. Dijkstra
Pieter U. Dijkstra
PWPaul M.N. Werker
Paul M.N. Werker

1 August 2019 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
MVMartinus M. van Veen
Martinus M. van Veen
JDJoseph R. Dusseldorp
Joseph R. Dusseldorp
OQOlivia Quatela
Olivia Quatela
JBJennifer Baiungo
Jennifer Baiungo
MRMara Robinson
Mara Robinson
THTessa A. Hadlock
Tessa A. Hadlock

1 December 2018 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
MVMartinus M. van Veen
Martinus M. van Veen
PDPieter U. Dijkstra
Pieter U. Dijkstra
SCSuzanne le Coultre
Suzanne le Coultre
MMMarc A.M. Mureau
Marc A.M. Mureau
PWPaul M.N. Werker
Paul M.N. Werker